TickerFacts.

Edesa Biotech, Inc. (EDSA): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$7.32M
Year ended 2025-09-30
-$8.91M
Trailing 12 months to 2026-06-30
2012-08-31: -$3.95M2013-08-31: -$2.80M2014-08-31: -$4.27M2015-09-30: -$4.41M2016-09-30: -$4.51M2017-09-30: -$4.70M2018-09-30: -$4.62M2020-09-30: -$4.99M2021-09-30: -$13.66M2022-09-30: -$12.28M2023-09-30: -$6.64M2024-09-30: -$4.89M2025-09-30: -$7.32M-$7.32M
2012-08-31 Operating Cash Flow (USD) 2025-09-30
Period endedOperating Cash FlowChange YoYSource filing
2025-09-30-$7.32Mn/m2025-12-12, From 2024-10-01
2024-09-30-$4.89Mn/m2025-12-12, From 2023-10-01
2023-09-30-$6.64Mn/m2024-12-13, From 2022-10-01
2022-09-30-$12.28Mn/m2023-12-15, From 2021-10-01
2021-09-30-$13.66Mn/m2022-12-16, From 2020-10-01
2020-09-30-$4.99Mn/a2021-12-28, From 2019-10-01
No annual figure between 2018-09-30 and 2020-09-30.
2018-09-30-$4.62Mn/m2018-11-30, From 2017-10-01
2017-09-30-$4.70Mn/m2018-11-30, From 2016-10-01
2016-09-30-$4.51Mn/m2017-12-01, From 2015-10-01
2015-09-30-$4.41Mn/a2017-12-01, From 2014-10-01
2014-08-31-$4.27Mn/m2016-12-14, From 2013-09-01
2013-08-31-$2.80Mn/m2015-12-14, From 2012-09-01
2012-08-31-$3.95Mn/a2014-11-21, From 2011-09-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Edesa Biotech, Inc. (EDSA)2025-09-30-$7.32Mn/m
CalciMedica, Inc. (CALC)2025-12-31-$21.18Mn/m
Chemomab Therapeutics Ltd. (CMMB)2025-12-31-$11.13Mn/m
CytoDyn Inc. (CYDY)2026-05-31-$17.25Mn/m
Actuate Therapeutics, Inc. (ACTU)2025-12-31-$19.21Mn/m
Exicure, Inc. (XCUR)2025-12-31-$8.55Mn/m
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$14.11Mn/m
PMGC Holdings Inc. (ELAB)2025-12-31-$5.93Mn/m
Biovie Inc. (BIVI)2026-06-30-$19.02Mn/m

Compare EDSA, CALC, CMMB, CYDY side by side · Screen every company in Pharmaceutical Preparations ↗